Document is current
Any future updates will be listed below
-
Authors
Polzer, Bernhard
Medoro, Gianni
Pasch, Sophie
Fontana, Francesca
Zorzino, Laura
Pestka, Aurelia
Andergassen, Ulrich
Meier‐Stiegen, Franziska
Czyz, Zbigniew T
Alberter, Barbara
Treitschke, Steffi
Schamberger, Thomas
Sergio, Maximilian
Bregola, Giulia
Doffini, Anna
Gianni, Stefano
Calanca, Alex
Signorini, Giulio
Bolognesi, Chiara
Hartmann, Arndt
Fasching, Peter A
Sandri, Maria T
Rack, Brigitte
Fehm, Tanja
Giorgini, Giuseppe
Manaresi, Nicolò
Klein, Christoph A
-
Funding
Funding for this research was provided by:
Bavarian State Ministry of Sciences, Research and the Arts (109753)
Deutsche Krebshilfe (DFG KL1233‐3)
- License Information
-
More Information
Article History
Received: 5 March 2014
Revised: 25 September 2014
Accepted: 29 September 2014
First Online: 30 October 2014
Conflict of interest
: GM, FF, MS, GB, AD, SG, AC, GS, CB, GG and NM are employed by Silicon Biosystems SpA, Bologna, Italy. GM, GG and NM have stock ownership of Silicon Biosystems Spa. CAK is inventor of the Ampli 1 ™ method.
